Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 1218778-77-8 Chemical Structure| 1218778-77-8

Structure of Sonidegib diphosphate
CAS No.: 1218778-77-8

Chemical Structure| 1218778-77-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

LDE225 diphosphate is a potent and selective Smo antagonist with IC50 of 1.3 nM and 2.5 nM for mouse and human Smo in binding assay, respectively.

Synonyms: NVP-LDE225 diphosphate; Erismodegib diphosphate; Sonidegib

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Sonidegib diphosphate

CAS No. :1218778-77-8
Formula : C26H32F3N3O11P2
M.W : 681.49
SMILES Code : O=C(C1=C(C)C(C(C=C2)=CC=C2OC(F)(F)F)=CC=C1)NC3=CC=C(N=C3)N4C[C@@H](C)O[C@@H](C)C4.O=P(O)(O)O.O=P(O)(O)O
Synonyms :
NVP-LDE225 diphosphate; Erismodegib diphosphate; Sonidegib
MDL No. :MFCD16627994
InChI Key :RWIVSVMMGFFZIJ-VWDRLOGHSA-N
Pubchem ID :45138699

Safety of Sonidegib diphosphate

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H360
Precautionary Statements:P201-P202-P280-P308+P313-P405-P501
Class:6.1
UN#:2811
Packing Group:

Related Pathways of Sonidegib diphosphate

Hedgehog

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
BV2 microglial cells 10 µM 24 hours Inhibited LPS-induced JNK phosphorylation Int J Mol Sci. 2022 Sep 13;23(18):10590
BV2 microglial cells 10 µM 24 hours Inhibited the LPS-induced IκBα phosphorylation and NF-κB nuclear translocation Int J Mol Sci. 2022 Sep 13;23(18):10590
BV2 microglial cells 10 µM 24 hours Inhibited the LPS-induced expression of iNOS and COX-2 Int J Mol Sci. 2022 Sep 13;23(18):10590
BV2 microglial cells 10 µM 24 hours Suppressed LPS-stimulated cell migration Int J Mol Sci. 2022 Sep 13;23(18):10590
BV2 microglial cells 10 µM 24 hours Inhibited LPS-induced MKK4 phosphorylation Int J Mol Sci. 2022 Sep 13;23(18):10590
BV2 microglial cells 10 µM 24 hours Inhibited LPS-induced c-Jun phosphorylation Int J Mol Sci. 2022 Sep 13;23(18):10590
BV2 microglial cells 30 µM 24 hours Reduced the LPS-induced production of IL-1β, IL-6, TNF-α, and NO Int J Mol Sci. 2022 Sep 13;23(18):10590
HS-5 cells 10 µM 48 hours To investigate the effect of Sonidegib on the adhesion of HS-5 bone marrow stromal spheroids to OCI-AML3 cells. Results showed that Sonidegib significantly prolonged the contact time required for leukemia cells to establish adhesive connections with the bone marrow stromal spheroid. Biomedicines. 2025 Feb 25;13(3):578
OCI-AML3 cells 10 µM 48 hours To investigate the effect of Sonidegib on the adhesion of OCI-AML3 cells to HS-5 bone marrow stromal spheroids. Results showed that Sonidegib significantly increased the minimum cell-to-cell adhesion time required for leukemic cells to establish adhesive bonds with bone marrow stromal cells, indicating a reduction in their adhesive properties. Biomedicines. 2025 Feb 25;13(3):578

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Human Patients with locally advanced basal cell carcinoma Oral 200 mg/day Once daily for a median duration of 7.8 months (range 6-11 months) To evaluate the efficacy and safety of Sonidegib alone or in combination with surgical excision for the treatment of locally advanced basal cell carcinomas. Results showed that 15 out of 29 lesions treated with Sonidegib alone achieved complete remission (CR), and 14 had partial remission (PR). All lesions treated with Sonidegib in association with surgical excision achieved CR. Oncologist. 2022 Jun 8;27(6):e533
ICR mice LPS-induced neuroinflammation model Oral 40 mg/kg Once daily for 7 days Attenuated IL-6 and TNF-α levels in the brains of LPS-treated mice Int J Mol Sci. 2022 Sep 13;23(18):10590
BALB/c mice Breast cancer bone metastasis model Oral 50 mg/kg Once daily until the mice were sacrificed To evaluate the inhibitory effect of Sonidegib on breast cancer bone metastasis. Sonidegib treatment reduced ALP expression around tumor cells and recovered NK cell infiltration in bone lesions, leading to alleviated bone metastasis burden, and extended survival of the mice. Cell Res. 2023 Jun;33(6):464-478

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT04806646 Locally Advanced Basal Cell Ca... More >>rcinoma Less << PHASE2 RECRUITING 2026-01-12 Asst Degli Spedali Civili Di B... More >>rescia, Brescia, Italy Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.47mL

0.29mL

0.15mL

7.34mL

1.47mL

0.73mL

14.67mL

2.93mL

1.47mL

References

 

Historical Records

Categories